Cargando…
Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque
Background and Aims: Acute coronary syndrome (ACS) is a group of clinical syndromes characterized by rupture or erosion of atherosclerotic unstable plaques. Effective intervention for vulnerable plaques (VP) is of great significance to reduce adverse cardiovascular events. Methods: Fbn1(C1039G+/−) m...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007762/ https://www.ncbi.nlm.nih.gov/pubmed/33796572 http://dx.doi.org/10.3389/fcvm.2021.642751 |
_version_ | 1783672555398234112 |
---|---|
author | Wang, Xueyu Fu, Yahong Xie, Zulong Cao, Muhua Qu, Wenbo Xi, Xiangwen Zhong, Shan Piao, Minghui Peng, Xiang Jia, Ying Meng, Lingbo Tian, Jinwei |
author_facet | Wang, Xueyu Fu, Yahong Xie, Zulong Cao, Muhua Qu, Wenbo Xi, Xiangwen Zhong, Shan Piao, Minghui Peng, Xiang Jia, Ying Meng, Lingbo Tian, Jinwei |
author_sort | Wang, Xueyu |
collection | PubMed |
description | Background and Aims: Acute coronary syndrome (ACS) is a group of clinical syndromes characterized by rupture or erosion of atherosclerotic unstable plaques. Effective intervention for vulnerable plaques (VP) is of great significance to reduce adverse cardiovascular events. Methods: Fbn1(C1039G+/−) mice were crossbred with LDLR(−/−) mice to obtain a novel model for atherosclerotic VP. After the mice were fed with a high-fat diet (HFD) for 12 or 24 weeks, pathological staining and immunohistochemistry analyses were employed to evaluate atherosclerotic lesions. Results: Compared to control mice, Fbn1(C1039G+/−)LDLR(−/−) mice developed more severe atherosclerotic lesions, and the positive area of oil red O staining in the aortic sinus was significantly increased after 12 weeks (21.7 ± 2.0 vs. 6.3 ± 2.1) and 24 weeks (32.6 ± 2.5 vs. 18.7 ± 2.6) on a HFD. Additional vulnerable plaque characteristics, including significantly larger necrotic cores (280 ± 19 vs. 105 ± 7), thinner fiber caps (14.0 ± 2.8 vs. 32.6 ± 2.7), apparent elastin fiber fragmentation and vessel dilation (3,010 ± 67 vs. 1,465 ± 49), a 2-fold increase in macrophage number (8.5 ± 1.0 vs. 5.0 ± 0.6), obviously decreased smooth muscle cell number (0.6 ± 0.1 vs. 2.1 ± 0.2) and an ~25% decrease in total collagen content (33.6 ± 0.3 vs. 44.9 ± 9.1) were observed in Fbn1(C1039G+/−)LDLR(−/−) mice compared with control mice after 24 weeks. Furthermore, spontaneous plaque rupture, neovascularization, and intraplaque hemorrhage were detected in the model mouse plaque regions but not in those of the control mice. Conclusions: Plaques in Fbn1(C1039G+/−)LDLR(−/−) mice fed a HFD show many features of human advanced atherosclerotic unstable plaques. These results suggest that the Fbn1(C1039G+/−)LDLR(−/−) mouse is a novel model for investigating the pathological and physiological mechanisms of advanced atherosclerotic unstable plaques. |
format | Online Article Text |
id | pubmed-8007762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80077622021-03-31 Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque Wang, Xueyu Fu, Yahong Xie, Zulong Cao, Muhua Qu, Wenbo Xi, Xiangwen Zhong, Shan Piao, Minghui Peng, Xiang Jia, Ying Meng, Lingbo Tian, Jinwei Front Cardiovasc Med Cardiovascular Medicine Background and Aims: Acute coronary syndrome (ACS) is a group of clinical syndromes characterized by rupture or erosion of atherosclerotic unstable plaques. Effective intervention for vulnerable plaques (VP) is of great significance to reduce adverse cardiovascular events. Methods: Fbn1(C1039G+/−) mice were crossbred with LDLR(−/−) mice to obtain a novel model for atherosclerotic VP. After the mice were fed with a high-fat diet (HFD) for 12 or 24 weeks, pathological staining and immunohistochemistry analyses were employed to evaluate atherosclerotic lesions. Results: Compared to control mice, Fbn1(C1039G+/−)LDLR(−/−) mice developed more severe atherosclerotic lesions, and the positive area of oil red O staining in the aortic sinus was significantly increased after 12 weeks (21.7 ± 2.0 vs. 6.3 ± 2.1) and 24 weeks (32.6 ± 2.5 vs. 18.7 ± 2.6) on a HFD. Additional vulnerable plaque characteristics, including significantly larger necrotic cores (280 ± 19 vs. 105 ± 7), thinner fiber caps (14.0 ± 2.8 vs. 32.6 ± 2.7), apparent elastin fiber fragmentation and vessel dilation (3,010 ± 67 vs. 1,465 ± 49), a 2-fold increase in macrophage number (8.5 ± 1.0 vs. 5.0 ± 0.6), obviously decreased smooth muscle cell number (0.6 ± 0.1 vs. 2.1 ± 0.2) and an ~25% decrease in total collagen content (33.6 ± 0.3 vs. 44.9 ± 9.1) were observed in Fbn1(C1039G+/−)LDLR(−/−) mice compared with control mice after 24 weeks. Furthermore, spontaneous plaque rupture, neovascularization, and intraplaque hemorrhage were detected in the model mouse plaque regions but not in those of the control mice. Conclusions: Plaques in Fbn1(C1039G+/−)LDLR(−/−) mice fed a HFD show many features of human advanced atherosclerotic unstable plaques. These results suggest that the Fbn1(C1039G+/−)LDLR(−/−) mouse is a novel model for investigating the pathological and physiological mechanisms of advanced atherosclerotic unstable plaques. Frontiers Media S.A. 2021-03-16 /pmc/articles/PMC8007762/ /pubmed/33796572 http://dx.doi.org/10.3389/fcvm.2021.642751 Text en Copyright © 2021 Wang, Fu, Xie, Cao, Qu, Xi, Zhong, Piao, Peng, Jia, Meng and Tian. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Wang, Xueyu Fu, Yahong Xie, Zulong Cao, Muhua Qu, Wenbo Xi, Xiangwen Zhong, Shan Piao, Minghui Peng, Xiang Jia, Ying Meng, Lingbo Tian, Jinwei Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque |
title | Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque |
title_full | Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque |
title_fullStr | Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque |
title_full_unstemmed | Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque |
title_short | Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque |
title_sort | establishment of a novel mouse model for atherosclerotic vulnerable plaque |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007762/ https://www.ncbi.nlm.nih.gov/pubmed/33796572 http://dx.doi.org/10.3389/fcvm.2021.642751 |
work_keys_str_mv | AT wangxueyu establishmentofanovelmousemodelforatheroscleroticvulnerableplaque AT fuyahong establishmentofanovelmousemodelforatheroscleroticvulnerableplaque AT xiezulong establishmentofanovelmousemodelforatheroscleroticvulnerableplaque AT caomuhua establishmentofanovelmousemodelforatheroscleroticvulnerableplaque AT quwenbo establishmentofanovelmousemodelforatheroscleroticvulnerableplaque AT xixiangwen establishmentofanovelmousemodelforatheroscleroticvulnerableplaque AT zhongshan establishmentofanovelmousemodelforatheroscleroticvulnerableplaque AT piaominghui establishmentofanovelmousemodelforatheroscleroticvulnerableplaque AT pengxiang establishmentofanovelmousemodelforatheroscleroticvulnerableplaque AT jiaying establishmentofanovelmousemodelforatheroscleroticvulnerableplaque AT menglingbo establishmentofanovelmousemodelforatheroscleroticvulnerableplaque AT tianjinwei establishmentofanovelmousemodelforatheroscleroticvulnerableplaque |